213 related articles for article (PubMed ID: 36422199)
1. Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer.
Simic P; Pljesa I; Nejkovic L; Jerotic D; Coric V; Stulic J; Kokosar N; Popov D; Savic-Radojevic A; Pazin V; Pljesa-Ercegovac M
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422199
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.
Sawers L; Ferguson MJ; Ihrig BR; Young HC; Chakravarty P; Wolf CR; Smith G
Br J Cancer; 2014 Sep; 111(6):1150-8. PubMed ID: 25010864
[TBL] [Abstract][Full Text] [Related]
4. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.
Diah SK; Smitherman PK; Townsend AJ; Morrow CS
Toxicol Appl Pharmacol; 1999 Jun; 157(2):85-93. PubMed ID: 10366541
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 130b enhances drug resistance in human ovarian cancer cells.
Zong C; Wang J; Shi TM
Tumour Biol; 2014 Dec; 35(12):12151-6. PubMed ID: 25155039
[TBL] [Abstract][Full Text] [Related]
6. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).
Mutallip M; Nohata N; Hanazawa T; Kikkawa N; Horiguchi S; Fujimura L; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Mol Med; 2011 Mar; 27(3):345-52. PubMed ID: 21181092
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide storage and transport in cells are mediated by glutathione S-transferase P1-1 and multidrug resistance protein 1 via dinitrosyl iron complexes.
Lok HC; Rahmanto YS; Hawkins CL; Kalinowski DS; Morrow CS; Townsend AJ; Ponka P; Richardson DR
J Biol Chem; 2012 Jan; 287(1):607-618. PubMed ID: 22084240
[TBL] [Abstract][Full Text] [Related]
10. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.
Peklak-Scott C; Smitherman PK; Townsend AJ; Morrow CS
Mol Cancer Ther; 2008 Oct; 7(10):3247-55. PubMed ID: 18852128
[TBL] [Abstract][Full Text] [Related]
11. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1.
Sánchez-Gómez FJ; Díez-Dacal B; Pajares MA; Llorca O; Pérez-Sala D
Mol Pharmacol; 2010 Oct; 78(4):723-33. PubMed ID: 20631055
[TBL] [Abstract][Full Text] [Related]
12. Expression of genes for redox-dependent glutathione S-transferase isoforms GSTP1-1 and GSTA4-4 in tumor cell during the development doxorubicin resistance.
Kalinina EV; Chernov NN; Saprin AN; Kotova YN; Remizov VI; Shcherbak NP
Bull Exp Biol Med; 2007 Mar; 143(3):328-30. PubMed ID: 18225754
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
Gynecol Oncol; 2006 Feb; 100(2):330-7. PubMed ID: 16199080
[TBL] [Abstract][Full Text] [Related]
14. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p.
Ghanbarian M; Afgar A; Yadegarazari R; Najafi R; Teimoori-Toolabi L
Biomed Pharmacother; 2018 Dec; 108():1070-1080. PubMed ID: 30372807
[TBL] [Abstract][Full Text] [Related]
15. Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer.
Yang F; Gao B; Chen W; Du E; Liang Y; Hu X; Yang X
Medicine (Baltimore); 2018 Oct; 97(41):e12364. PubMed ID: 30313031
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN; Vlahos NF
Int J Gynecol Cancer; 2010 Jul; 20(5):732-7. PubMed ID: 20966642
[TBL] [Abstract][Full Text] [Related]
17. Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells.
Morrow CS; Smitherman PK; Townsend AJ
Mol Carcinog; 2000 Nov; 29(3):170-8. PubMed ID: 11108662
[TBL] [Abstract][Full Text] [Related]
18. [The expression of multiple drug resistance associated genes in ovarian cancer].
Cheng G; Zhu H; Sun L
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):87-90. PubMed ID: 11809106
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase P1 c.313A > G polymorphism could be useful in the prediction of doxorubicin response in breast cancer patients.
Romero A; Martín M; Oliva B; de la Torre J; Furio V; de la Hoya M; García-Sáenz JA; Moreno A; Román JM; Diaz-Rubio E; Caldés T
Ann Oncol; 2012 Jul; 23(7):1750-6. PubMed ID: 22052985
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase Pi 1 is a valuable predictor for cancer drug resistance in esophageal squamous cell carcinoma.
Ogino S; Konishi H; Ichikawa D; Matsubara D; Shoda K; Arita T; Kosuga T; Komatsu S; Shiozaki A; Okamoto K; Kishimoto M; Otsuji E
Cancer Sci; 2019 Feb; 110(2):795-804. PubMed ID: 30499150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
